Patents by Inventor Lingdi Zhang

Lingdi Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADVANCED RNA TARGETING (ARNATAR)
    Publication number: 20250101423
    Abstract: Disclosed herein are Advanced RNA Targeting (ARNATAR) oligomeric compounds, thoughtfully designed compounds for inhibiting gene expression through the RISC pathway. Such compounds are useful in methods for reducing expression of certain genes, many of which are associated with a variety of diseases and disorders.
    Type: Application
    Filed: July 31, 2024
    Publication date: March 27, 2025
    Inventors: Xuehai Liang, Lingdi Zhang, Yanfeng Wang
  • Advanced RNA targeting (ARNATAR) for angiotensinogen
    Patent number: 12247204
    Abstract: Disclosed herein are Advanced RNA Targeting (ARNATAR) dsRNA compounds targeting angiotensinogen (AGT). Such compounds are useful in methods for reducing expression of AGT and for therapeutically treating RAAS associated diseases, disorders and/or conditions, or symptoms thereof in a subject.
    Type: Grant
    Filed: June 21, 2024
    Date of Patent: March 11, 2025
    Assignee: ARNATAR THERAPEUTICS, INC
    Inventors: Yen Lieu, Lingdi Zhang, Xuehai Liang, Yanfeng Wang
  • ADVANCED RNA TARGETING (ARNATAR) FOR ANGIOTENSINOGEN
    Publication number: 20250066779
    Abstract: Disclosed herein are Advanced RNA Targeting (ARNATAR) dsRNA compounds targeting angiotensinogen (AGT). Such compounds are useful in methods for reducing expression of AGT and for therapeutically treating RAAS associated diseases, disorders and/or conditions, or symptoms thereof in a subject.
    Type: Application
    Filed: June 21, 2024
    Publication date: February 27, 2025
    Inventors: Yen Lieu, Lingdi Zhang, Xuehai Liang, Yanfeng Wang